tiprankstipranks
Trending News
More News >
Mochida Pharmaceutical Co., Ltd. (JP:4534)
:4534
Japanese Market

Mochida Pharmaceutical Co., Ltd. (4534) Income Statement

Compare
1 Followers

Mochida Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q3 2024), Mochida Pharmaceutical Co., Ltd.'s total revenue was ¥29.64B, an increase of 3.11% from the same quarter last year. In Q3, Mochida Pharmaceutical Co., Ltd.'s net income was ¥2.78B. See Mochida Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 105.16B¥ 102.89B¥ 103.26B¥ 110.18B¥ 103.00B
Gross Profit
¥ 53.79B¥ 52.07B¥ 55.12B¥ 59.55B¥ 54.79B
Operating Expenses
¥ 45.66B¥ 46.27B¥ 46.61B¥ 45.16B¥ 42.79B
Depreciation and Amortization
¥ 2.94B¥ 2.81B¥ 2.67B¥ 2.69B¥ 2.74B
EBITDA
¥ 11.00B¥ 8.61B¥ 11.71B¥ 17.28B¥ 14.75B
Operating Income
¥ 8.13B¥ 5.80B¥ 8.51B¥ 14.39B¥ 12.00B
Other Income/Expenses
¥ -75.00M¥ 358.00M¥ 537.00M¥ 199.00M¥ -103.00M
Pretax Income
¥ 8.05B¥ 6.16B¥ 9.04B¥ 14.59B¥ 11.90B
Net Income
¥ 5.68B¥ 4.55B¥ 6.65B¥ 10.57B¥ 8.59B
Per Share Metrics
Basic EPS
¥ 160.36¥ 126.79¥ 178.93¥ 277.39¥ 222.27
Diluted EPS
¥ 160.36¥ 126.79¥ 178.93¥ 277.39¥ 222.27
Weighted Average Shares Outstanding
35.45M 35.86M 37.16M 38.10M 38.63M
Weighted Average Shares Outstanding (Diluted)
35.45M 35.86M 37.16M 38.10M 38.63M
Currency in JPY

Mochida Pharmaceutical Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis